SCHEMBL9622341

SCHEMBL9622341

CCC1(c2ccccc2)C(=O)NC(=O)N(CCCCC(=O)O)C1=O

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.61
LMNA P02545 2/20 0.59
KMT2A Q03164 2/20 0.55
MMP2 P08253 2/20 0.44
MMP3 P08254 2/20 0.44
MMP9 P14780 2/20 0.44
BACE1 P56817 1/20 0.43
BACE2 Q9Y5Z0 1/20 0.43
MEN1 O00255 1/20 0.43
CYP1A2 P05177 1/20 0.43
POLB P06746 1/20 0.43
TSHR P16473 1/20 0.43
APEX1 P27695 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
PTGS1 P23219 4/20 0.41
PTGS2 P35354 4/20 0.41
FAAH O00519 1/20 0.40
FABP4 P15090 1/20 0.39
FABP5 Q01469 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7045940 1.00 CYP2C19 (0.61) CYP2C19LMNAKMT2AMMP2MMP3
SCHEMBL8749863 1.00 CYP2C19 (0.61) CYP2C19LMNAKMT2AMMP2MMP3
SCHEMBL8838995 0.96 CYP2C19 (0.62) CYP2C19LMNAKMT2AMMP2MMP3
SCHEMBL7799794 0.96 CYP2C19 (0.62) CYP2C19LMNAKMT2AMMP2MMP3
SCHEMBL9507072 0.91 CYP2C19 (0.65) CYP2C19LMNAKMT2AMMP2MMP3
SCHEMBL7776762 0.90 CYP2C19 (0.62) CYP2C19LMNAKMT2AMMP2MMP3
SCHEMBL7775183 0.88 CYP2C19 (0.51) CYP2C19LMNAKMT2AMMP2MMP9
SCHEMBL9621846 0.87 CYP2C19 (0.55) CYP2C19LMNAKMT2AMMP2MMP3
SCHEMBL7773269 0.87 CYP2C19 (0.50) CYP2C19LMNAKMT2ACYP1A2TSHR
SCHEMBL7776791 0.84 CYP2C19 (0.52) CYP2C19LMNAKMT2AMMP2MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102323414-B Phenobarbital homogeneous-phase enzyme immunoassay reagent kit and preparation method thereof XI AN KINGMED MEDICAL INST CO LTD 2013-09-11 CN disclosed
CN-102323414-A Phenobarbital homogeneous-phase enzyme immunoassay reagent kit and preparation method thereof XI AN KINGMED MEDICAL INST CO LTD 2012-01-18 CN disclosed
EP-0212989-B1 LIPID VESICLES CONTAINING LABELED SPECIES AND THEIR ANALYTICAL USES EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1992-02-19 EP disclosed
EP-0215027-A4 LIPOSOME IMMUNOASSAY REAGENT AND METHOD. COOPER LIPOTECH INC (US) 1989-06-26 EP disclosed
US-4783400-A Homogeneous enzyme immunoassay system and method COOPER LIPOTECH (US) 1988-11-08 US disclosed
US-4752572-A Lipid vesicles containing labeled species and their analytical uses EASTMAN KODAK COMPANY (US) 1988-06-21 US disclosed
EP-0215027-A1 LIPOSOME IMMUNOASSAY REAGENT AND METHOD LIPOSOME TECHNOLOGY, INC. (US) 1987-03-25 EP disclosed
EP-0212989-A2 Lipid vesicles containing labeled species and their analytical uses EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1987-03-04 EP disclosed
WO-1986004682-A1 LIPOSOME IMMUNOASSAY REAGENT AND METHOD COOPER-LIPOTECH, INC. (US) 1986-08-14 WO disclosed